Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.86
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
4.33
Today|||52-Week Range
8.38
+4.52%
Year-to-Date

Today’s Trading

Previous close4.86
Today’s open4.84
Day’s range4.73 - 4.90
Volume486,051
Average volume (3 months)1,779,773
Market cap$577.1M
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+11.75%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.99+4.73%
TGTXTG Therapeutics Inc-0.03-0.27%
BYSIBeyondspring Inc+0.35+1.37%
EGRXEagle Pharmaceutical...-0.08-0.14%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts